BioSpace News Archive

Drug Development

Magenta Therapeutics Sets Sights on $100 Million IPO To Advance Bone Marrow Transplant Programs

Weeks after securing $52 million in a Series C financing, Magenta Therapeutics is eying the raising of $100 million in an initial public offering two years after it was launched by Third Rock Ventures and Atlas Venture with $48.5 million in Series A financing.

May 25, 2018
·
2 min read
·
Alex Keown
Drug Development

AstraZeneca’s Imfinzi Shows Positive Overall Survival Results in Lung Cancer Trial

AstraZeneca and its research-and-development unit MedImmune, announced positive overall survival (OS) data for its Phase III PACIFIC trial of Imfinzi (durvalumab) in patients with unresectable Stage III non-small cell lung cancer (NSCLC).

May 25, 2018
·
3 min read
·
Mark Terry
Drug Development

Prothena Slashes 57% of Employees in Reorganization Following Trial Failure

One month after Prothena Corporation shuttered its NEOD001 program for AL amyloidosis following a Phase IIb failure, the company initiated a reorganization that includes a workforce reduction of 57 percent.

May 25, 2018
·
2 min read
·
Alex Keown
10 Tips to Boost Your Credibility at Work

Credibility is an attribute that is part of your being, which is why you can’t fake it or establish it very quickly.

May 25, 2018
·
3 min read
·
Porschia Parker
10 Powerful Networking Tips to Further Your Career

Who is being hired for coveted roles and landing their dream jobs? Research shows it’s usually people with the most personal contact to decision makers.

May 25, 2018
·
4 min read
·
Porschia Parker